Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Interstitial Cystitis: early-phase trial registry
3 of 4 indexed Chronic Interstitial Cystitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 3 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Chronic Interstitial Cystitis: 4 US clinical trials tracked, 3 recruiting.
Chronic Interstitial Cystitis is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Wake Forest University Health Sciences, running 2 of these trials.
Enrollment posture brief
Registry condition chronic-interstitial-cystitis
OPEN 3 | RECR 75% | LATE 0 | EARLY 2 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Chronic Interstitial Cystitis lists 3 open slots (75% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Interstitial Cystitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Interstitial Cystitis is recruiting above its size-band peers.
3 of 4 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment
Vanderbilt University Medical Center
NCT06299683
Investigation of PEMF Therapy for Female Patients With IC/BPS
Wake Forest University Health Sciences
NCT05149573
Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
Wake Forest University Health Sciences
NCT04734106
A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions
Allergan
NCT01879683
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Interstitial Cystitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Interstitial Cystitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Interstitial Cystitis page
4 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Chronic Interstitial Cystitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Wake Forest University Health Sciences sponsors the most Chronic Interstitial Cystitis trials on record, review their full trial history before evaluating a specific study. See Wake Forest University Health Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Interstitial Cystitis condition card totals 4 registered trials; most-linked intervention LiRIS® 400 mg; top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.